After pre-announcing that its full-year revenue would come in below its original guidance, Eli Lilly (NYSE: LLY) announced ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Eli Lilly (LLY) reports Q4 earnings Thursday. LLY stock up 8.22% YTD. Chart shows strong bullish momentum with potential for ...

INDIANAPOLIS—Lilly Endowment Inc., a major shareholder in Eli Lilly & Co. (NYSE:LLY), has recently sold a significant portion ...

Eli Lilly and Company LLY will report its ... the company delivered a negative earnings surprise of 22.37%, as seen in the chart below. Lilly has an Earnings ESP of -2.08% and a Zacks Rank ...

Eli Lilly and Company LLY will report its fourth-quarter and full-year 2024 earnings on Feb. 6, before market open. The Zacks ...

Eli Lilly is set to report fourth-quarter earnings early Thursday, with analysts expecting rising sales and profit in the first full quarter with the company's weight-loss drugs no longer in shortage.

Pharmaceutical company Eli Lilly is ... Alpha rating Eli Lilly stock as a "buy," along with one "hold" rating. The lone hold rating is also the only analyst with a price target below the stock's ...

Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today and set a price ...

With its 2-star rating, we believe Eli Lilly’s stock is over-valued compared to ... receiving branded GLP-1 therapies. We think US prices could fall substantially as volumes increase (in line ...

Weight loss drugs are huge these days, and Eli Lilly (LLY) is leading the pack when it comes to these. However, today’s ...